These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 7102666)

  • 1. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.
    Barnett EV; Dornfeld L; Lee DB; Liebling MR
    J Rheumatol; 1978; 5(3):275-87. PubMed ID: 372523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of treatment in lupus nephritis: effects of prednisone.
    Pollak VE; Dosekun AK
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):170-7. PubMed ID: 7102665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
    Austin HA; Klippel JH; Balow JE; le Riche NG; Steinberg AD; Plotz PH; Decker JL
    N Engl J Med; 1986 Mar; 314(10):614-9. PubMed ID: 3511372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of proliferative lupus glomerulonephritis: a prospective trial in The Netherlands.
    van den Wall Bake AW; Berden JH; Derksen RH; de Glas-Vos JW; Hagen EC
    Neth J Med; 1994 Dec; 45(6):280-4. PubMed ID: 7838244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression from minimal or focal to diffuse proliferative lupus nephritis.
    Zimmerman SW; Jenkins PG; Shelf WD; Bloodworth JM; Burkholder PM
    Lab Invest; 1975 May; 32(5):665-72. PubMed ID: 1092911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide.
    Donadio JV; Holley KE; Ferguson RH; Ilstrup DM
    N Engl J Med; 1978 Nov; 299(21):1151-5. PubMed ID: 309095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis.
    Felson DT; Anderson J
    N Engl J Med; 1984 Dec; 311(24):1528-33. PubMed ID: 6390198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment with immunosuppressive agents in disseminated lupus erythematosus and in some evolutive nephropathies].
    Purice S; Ghelerter L; Matei I; Brunazian G
    Stud Cercet Med Interna; 1969; 10(2):147-53. PubMed ID: 5344004
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide.
    Donadio JV; Holley KE; Ferguson RH; Ilstrup DM
    Mayo Clin Proc; 1976 Aug; 51(8):484-94. PubMed ID: 950801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lupus nephritis.
    Pollak VE
    Adv Nephrol Necker Hosp; 1976; 6():137-61. PubMed ID: 828444
    [No Abstract]   [Full Text] [Related]  

  • 14. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC; Ying KY; Tang S; Leung CY; Lee KW; Ng WL; Wong RW; Lau CS
    Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of azathioprine on renal histology and function in lupus nephritis.
    Shelp WD; Bloodworth JM; Rieselbach RE
    Arch Intern Med; 1971 Oct; 128(4):566-73. PubMed ID: 5111661
    [No Abstract]   [Full Text] [Related]  

  • 17. Lupus nephritis: clinical course in relation to treatment.
    Nanra RS; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1193-210. PubMed ID: 4803309
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months.
    Decker JL; Klippel JH; Plotz PH; Steinberg AD
    Ann Intern Med; 1975 Nov; 83(5):606-15. PubMed ID: 1106278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive agents in lupus nephritis: a critical analysis.
    Wagner L
    Medicine (Baltimore); 1976 May; 55(3):239-50. PubMed ID: 775253
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of nephritis following disseminated lupus erythematosus with prednisone, azathioprine and cyclophosphamide].
    Michielsen J; Go IH
    Ned Tijdschr Geneeskd; 1974 Sep; 118(37):1403-5. PubMed ID: 4606008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.